Ex-Chelsea Tx CEO Oliveto Takes Head Seat at Galleon Pharma

Xconomy Raleigh-Durham — 

Joseph Oliveto steered Charlotte, NC-based Chelsea Therapeutics to a $658 million sale to Danish drugmaker Lundbeck A/S in May 2014. Today, he’s resurfaced as the new CEO of Galleon Pharmaceuticals, a Horsham, PA-based developer of treatments for sleep apnea and other breathing-control disorders. Galleon’s previous CEO, James Mannion, has retired and will serve as a strategic advisor.